Government Support to Back Brazil Generics Market

According to our latest report entitled “Brazil Generics Market Forecast to 2012”, factors like, increasing prevalence of diseases and expanding proportion of old people in the total population have significantly contributed to the development of generic drugs market in Brazil. In 2009, the market reached to the mark of BRL 4.5 Billion and is likely to grow at the CAGR of around of 19% during 2010-2012 to reach BRL 7.5 Billion by 2012. The share of generic drugs in total pharmaceutical industry has been rising at a fast pace and the attractive investment heading towards the region is further likely to strengthen market share.

 

Our report has found that the Brazilian government continues to provide immense support to the generics market in the form of liberal policies and better regulatory system. The policies have been aimed at providing cheaper drugs to poor social strata and for this the government has been negotiating with market players for providing cost effective products. Moreover, the policies for commercialization and better distribution of generic drugs are being pursued.

 

The report “Brazil Generics Market Forecast to 2012” covers all the aspects of Brazil generics market and identifies areas that tend to impact industry development in coming future. The report also provides current market trends and illustrates their significance from the market point of view. A complete analysis and reliable statistics regarding market has also been provided that takes into account recent developments and regulatory structure.

 

The report is an outcome of rational analysis and in-depth research of the Brazilian generics market with strong emphasis on data reliability and effective presentation. Forecasts presented in the report make use of strong base and techniques that seek to establish better future outlook. The report also covers the key active market players, their description, and recent developments. Overall, the report is expected to provide clients with complete picture of the Brazilian generics market and facilitate investment decision.

For more information visit: http://www.rncos.com/Report/IM249.htm